BioBridge Global (BBG) is helping make history as a partner of an Austin bioscience firm searching for a treatment for Ebola.
A team from South Texas Blood & Tissue Center (STBTC), which is now part of BBG, drew the blood of Ebola survivor Amber Vinson, a Dallas nurse who was infected with the virus in October while treating a man with the disease last fall. She has since recovered and is no longer contagious.
“We are thrilled to help our partner in this endeavor,” said Dr. Rachel Beddard, BBG medical director. “We have the means to provide raw materials for biomedical research, and we’ve been a partner of this firm for more than four years. We’re proud to be part of research that can make a difference worldwide.”